Cite
Antonetti P, Fargnoli MC, Porzio G, et al. A multicenter study of skin toxicity management in patients with left-sided, RAS/BRAF wild-type metastatic colorectal cancer treated with first-line anti-EGFR-based doublet regimen: is there room for improvement?. Support Care Cancer. 2021;doi: 10.1007/s00520-021-06652-5.
Antonetti, P., Fargnoli, M. C., Porzio, G., Salvatore, L., Filippi, R., Ghidini, M., Nigro, O., Gelsomino, F., Zurlo, I. V., Dell'Aquila, E., Lombardi, P., Keränen, S. R., Depetris, I., Giampieri, R., Morelli, C., De Tursi, M., Di Pietro, F. R., Zanaletti, N., Vitale, P., Garajova, I., Spinelli, G. P., Zoratto, F., Roberto, M., Petrillo, A., Aimar, G., Cortellini, A., Pensieri, M. V., Ficorella, C., Ferri, C., & Parisi, A. (2021). A multicenter study of skin toxicity management in patients with left-sided, RAS/BRAF wild-type metastatic colorectal cancer treated with first-line anti-EGFR-based doublet regimen: is there room for improvement?. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, . https://doi.org/10.1007/s00520-021-06652-5
Antonetti, Paolo, et al. "A multicenter study of skin toxicity management in patients with left-sided, RAS/BRAF wild-type metastatic colorectal cancer treated with first-line anti-EGFR-based doublet regimen: is there room for improvement?." Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer vol. (2021). doi: https://doi.org/10.1007/s00520-021-06652-5
Antonetti P, Fargnoli MC, Porzio G, Salvatore L, Filippi R, Ghidini M, Nigro O, Gelsomino F, Zurlo IV, Dell'Aquila E, Lombardi P, Keränen SR, Depetris I, Giampieri R, Morelli C, De Tursi M, Di Pietro FR, Zanaletti N, Vitale P, Garajova I, Spinelli GP, Zoratto F, Roberto M, Petrillo A, Aimar G, Cortellini A, Pensieri MV, Ficorella C, Ferri C, Parisi A. A multicenter study of skin toxicity management in patients with left-sided, RAS/BRAF wild-type metastatic colorectal cancer treated with first-line anti-EGFR-based doublet regimen: is there room for improvement?. Support Care Cancer. 2021 Nov 15; doi: 10.1007/s00520-021-06652-5. Epub 2021 Nov 15. PMID: 34779921.
Copy
Download .nbib